je.st
news
Tag: research
Research And Markets: Reverse Costing Analysis Of Bosch's Mid Range Radar (MRR) Sensor
2015-11-03 05:29:04| rfglobalnet Home Page
Research and Markets has announced the addition of the "Bosch Mid Range Radar (MRR) Sensor - Reverse Costing Analysis" report to their offering.
Tags: research
range
analysis
mid
OMEICOS Receives BMBF Research Grant To Advance Its Novel Approach To Treat Atrial Fibrillation
2015-11-03 05:07:41| drugdiscoveryonline News Articles
OMEICOS Therapeutics, a biopharmaceutical company developing first-in-class small molecule therapeutics for the prevention and treatment of cardiovascular diseases including atrial fibrillation, recently announced the approval of an approximately €1.7Mgrant by the German Ministry of Education and Research (BMBF)
Tags: research
approach
advance
grant
Keysight Technologies Collaborates With China Southeast University On 5G Massive MIMO Research
2015-11-03 04:52:52| rfglobalnet Home Page
Keysight Technologies, Inc. recently announced it will collaborate with China Southeast University (www.seu.edu.cn) to research test and measurement technologies for 5G Massive MIMO.
Tags: research
china
university
technologies
Keysight Technologies Collaborates With China Southeast University On 5G Massive MIMO Research
2015-11-03 04:52:52| wirelessdesignonline News Articles
Keysight Technologies, Inc. recently announced it will collaborate with China Southeast University (www.seu.edu.cn) to research test and measurement technologies for 5G Massive MIMO.
Tags: research
china
university
technologies
Acceleron Highlights Phase 3 Studies, New Clinical Results And Research Strategies At Research And Development Day Event
2015-11-03 04:51:04| drugdiscoveryonline Home Page
Acceleron Pharma Inc., a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutic candidates that regulate cellular growth and repair, recently announced the phase 3 clinical trial designs for the luspatercept program in myelodysplastic syndromes (“MEDALIST” study) and beta-thalassemia (“BELIEVE” study), phase 1 preliminary results from the ACE-083 program, and its new IntelliTrapdrug discovery platform
Tags: day
results
research
development
Sites : [572] [573] [574] [575] [576] [577] [578] [579] [580] [581] [582] [583] [584] [585] [586] [587] [588] [589] [590] [591] next »